 @article{Fujimura_2024, title={A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial}, volume={191}, ISSN={1365-2133}, url={http://dx.doi.org/10.1093/bjd/ljae231}, DOI={10.1093/bjd/ljae231}, number={5}, journal={British Journal of Dermatology}, publisher={Oxford University Press (OUP)}, author={Fujimura, Taku and Yoshino, Koji and Kato, Hiroshi and Fukushima, Satoshi and Ishizuki, Shoichiro and Otsuka, Atsushi and Matsushita, Shigeto and Amagai, Ryo and Muto, Yusuke and Yamazaki, Emi and Kambayashi, Yumi and Yahata, Takashi and Miyata, Toshio and Fujisawa, Yasuhiro and Asano, Yoshihide}, year={2024}, month=jun, pages={691â€“697} }
